Hupa, Nalman B.
HRN: 21-70-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2022
CEFTRIAXONE 1G (VIAL)
08/04/2022
08/11/2022
IV
2g
Od
Periappendicial Abscess
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes